Deota Shaunak, Panda Satchidananda
The Salk Institute for Biological Studies, La Jolla, California, USA.
J Clin Endocrinol Metab. 2021 Mar 8;106(3):e1488-e1493. doi: 10.1210/clinem/dgaa691.
Metabolic homeostasis is achieved by endocrine factors, signaling cascades, and metabolic pathways that sense and respond to metabolic demands in different organs. However, the recent discovery that almost every component of this regulatory system is also modulated by circadian rhythm highlights novel etiology and prognosis of metabolic diseases. First, chronic circadian rhythm disruption, as in shiftwork or shiftwork-like lifestyle, can increase the risk for metabolic diseases. Second, by understanding factors that affect circadian rhythm, we can implement new behavioral or pharmacological interventions for the prevention and management of metabolic disorders. One of these novel circadian-based interventions is time-restricted eating (TRE) in which all daily caloric intake is restricted to a consistent window of 8 to 12 hours. In preclinical animal models, TRE can prevent or reverse many metabolic diseases. Circadian research has also catalyzed attempts to optimally time the dosing of existing drugs to treat metabolic diseases or develop new drugs that target the circadian clock to treat metabolic disorders.
代谢稳态是由内分泌因子、信号级联反应和代谢途径实现的,这些因子、反应和途径能够感知并响应不同器官的代谢需求。然而,最近的发现表明,这个调节系统的几乎每个组成部分也都受到昼夜节律的调节,这凸显了代谢疾病的新病因和预后。首先,慢性昼夜节律紊乱,如轮班工作或类似轮班工作的生活方式,会增加患代谢疾病的风险。其次,通过了解影响昼夜节律的因素,我们可以实施新的行为或药物干预措施来预防和管理代谢紊乱。这些基于昼夜节律的新干预措施之一是限时进食(TRE),即把每日所有热量摄入限制在8至12小时的固定时间段内。在临床前动物模型中,限时进食可以预防或逆转许多代谢疾病。昼夜节律研究还促使人们尝试优化现有治疗代谢疾病药物的给药时间,或开发针对生物钟的新药来治疗代谢紊乱。